Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
J. Clin. Med. 2014, 3(2), 663-678; doi:10.3390/jcm3020663
Review

Microarray Technology for the Diagnosis of Fetal Chromosomal Aberrations: Which Platform Should We Use?

1,†
, 1,†
 and 2,3,4,†,*
Received: 19 February 2014; in revised form: 28 March 2014 / Accepted: 1 April 2014 / Published: 20 June 2014
(This article belongs to the Special Issue Prenatal Genetic Screening and Diagnosis-Part 2)
View Full-Text   |   Download PDF [694 KB, uploaded 20 June 2014]
Abstract: The advantage of microarray (array) over conventional karyotype for the diagnosis of fetal pathogenic chromosomal anomalies has prompted the use of microarrays in prenatal diagnostics. In this review we compare the performance of different array platforms (BAC, oligonucleotide CGH, SNP) and designs (targeted, whole genome, whole genome, and targeted, custom) and discuss their advantages and disadvantages in relation to prenatal testing. We also discuss the factors to consider when implementing a microarray testing service for the diagnosis of fetal chromosomal aberrations.
Keywords: prenatal microarray; implementation; BAC; SNP prenatal microarray; implementation; BAC; SNP
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Karampetsou, E.; Morrogh, D.; Chitty, L. Microarray Technology for the Diagnosis of Fetal Chromosomal Aberrations: Which Platform Should We Use? J. Clin. Med. 2014, 3, 663-678.

AMA Style

Karampetsou E, Morrogh D, Chitty L. Microarray Technology for the Diagnosis of Fetal Chromosomal Aberrations: Which Platform Should We Use? Journal of Clinical Medicine. 2014; 3(2):663-678.

Chicago/Turabian Style

Karampetsou, Evangelia; Morrogh, Deborah; Chitty, Lyn. 2014. "Microarray Technology for the Diagnosis of Fetal Chromosomal Aberrations: Which Platform Should We Use?" J. Clin. Med. 3, no. 2: 663-678.

J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert